BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fakhroo A, AlKhatib HA, Al Thani AA, Yassine HM. Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity. Vaccines (Basel) 2021;9:1168. [PMID: 34696276 DOI: 10.3390/vaccines9101168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Pecoraro V, Pirotti T, Trenti T. Evidence of SARS-CoV-2 reinfection: analysis of 35,000 subjects and overview of systematic reviews. Clin Exp Med 2022. [PMID: 36289100 DOI: 10.1007/s10238-022-00922-0] [Reference Citation Analysis]
2 Orendáčová M, Kvašňák E. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Front Public Health 2022;10:903568. [DOI: 10.3389/fpubh.2022.903568] [Reference Citation Analysis]
3 Chivu-economescu M, Vremera T, Ruta SM, Grancea C, Leustean M, Chiriac D, David A, Matei L, Diaconu CC, Gatea A, Ilie C, Radu I, Cornienco AM, Iancu LS, Cirstoiu C, Pop CS, Petru R, Strambu V, Malciolu S, Popescu CP, Florescu SA, Rafila A, Furtunescu FL, Pistol A. Assessment of the Humoral Immune Response Following COVID-19 Vaccination in Healthcare Workers: A One Year Longitudinal Study. Biomedicines 2022;10:1526. [DOI: 10.3390/biomedicines10071526] [Reference Citation Analysis]
4 Zuo F, Abolhassani H, Du L, Piralla A, Bertoglio F, de Campos-Mata L, Wan H, Schubert M, Cassaniti I, Wang Y, Sammartino JC, Sun R, Vlachiotis S, Bergami F, Kumagai-Braesch M, Andréll J, Zhang Z, Xue Y, Wenzel EV, Calzolai L, Varani L, Rezaei N, Chavoshzadeh Z, Baldanti F, Hust M, Hammarström L, Marcotte H, Pan-Hammarström Q. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nat Commun 2022;13:2670. [PMID: 35562366 DOI: 10.1038/s41467-022-30340-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
5 Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci 2022;23:1716. [PMID: 35163638 DOI: 10.3390/ijms23031716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
6 Mendiola-pastrana IR, López-ortiz E, Río de la Loza-zamora JG, González J, Gómez-garcía A, López-ortiz G. SARS-CoV-2 Variants and Clinical Outcomes: A Systematic Review. Life 2022;12:170. [DOI: 10.3390/life12020170] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
7 Zuo F, Abolhassani H, Du L, Piralla A, Bertoglio F, de Campos-mata L, Wan H, Schubert M, Wang Y, Sun R, Cassaniti I, Vlachiotis S, Kumagai-braesch M, Andréll J, Zhang Z, Xue Y, Wenzel EV, Calzolai L, Varani L, Rezaei N, Chavoshzadeh Z, Baldanti F, Hust M, Hammarström L, Marcotte H, Pan-hammarström Q. Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant.. [DOI: 10.1101/2022.01.04.22268755] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
8 Mensah AA, Campbell H, Stowe J, Seghezzo G, Simmons R, Lacy J, Bukasa A, O’boyle S, Ramsay ME, Brown K, Ladhani S. Risk of SARS-CoV-2 reinfections in children: prospective national surveillance, January 2020 to July 2021, England.. [DOI: 10.1101/2021.12.10.21267372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]